2018
DOI: 10.1021/acschembio.8b00558
|Get access via publisher |Summarize |Cite
|
Sign up to set email alerts

A Guanidine-Based Synthetic Compound Suppresses Angiogenesis via Inhibition of Acid Ceramidase

Abstract: Angiogenesis generates new blood vessels from pre-existing vessels. Tumors induce the formation of new blood vessels to ensure sufficient oxygen and nutrients for their growth. Normally, angiogenesis is induced by various pro-angiogenesis factors, including vascular endothelial growth factor (VEGF). Inhibition of VEGF is a promising approach to cancer treatment. A guanidine-based synthetic compound, E2, was identified as a potent hit from 68 guanidine-based derivatives by screening for angiogenesis inhibitors … Show more

Search citation statements

Order By: Relevance

Paper Sections

Select...
13
5
1
0

Citation Types

0
11
0
0

Year Published

Range
2019
2019
2025
2025

Publication Types

Select...
14
2
1
1

Relationship

1
17

Authors

Journals

citations

Cited by 18 publications

(11 citation statements)
references

References 40 publications

0
11
0
0
Order By: Relevance
How this paper cites the one you are viewing
“…It should be noted in conclusion, that chemists continue to use thiourea oxides in the synthesis of guanidine-based pharmaceuticals. Thus, in 2019 Cho and coworkers have received guanidine-based compound which suppresses angiogenesis in human umbilical vein ebdothelial cells [26]. In the intermediate steps of the synthesis of this compound they used thiourea trioxide.…”
Section: Discussion
mentioning
confidence: 99%